X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (778) 778
index medicus (609) 609
hematology (452) 452
thrombopoietin (408) 408
receptors, thrombopoietin - agonists (399) 399
thrombocytopenia (363) 363
female (328) 328
male (321) 321
eltrombopag (287) 287
purpura, thrombocytopenic, idiopathic - drug therapy (266) 266
romiplostim (247) 247
adult (233) 233
middle aged (225) 225
thrombopoietin - therapeutic use (219) 219
platelet count (217) 217
benzoates - therapeutic use (196) 196
hydrazines - therapeutic use (196) 196
pyrazoles - therapeutic use (196) 196
receptors, fc - therapeutic use (195) 195
immune thrombocytopenia (194) 194
purpura (191) 191
recombinant fusion proteins - therapeutic use (179) 179
animals (177) 177
aged (166) 166
thrombocytopenia - drug therapy (159) 159
platelets (153) 153
efficacy (147) 147
treatment outcome (139) 139
splenectomy (136) 136
thrombopoietin receptor agonist (129) 129
oncology (126) 126
itp (106) 106
management (105) 105
double-blind (104) 104
pharmacology & pharmacy (104) 104
mice (101) 101
thrombopoietin - pharmacology (101) 101
blood platelets (100) 100
safety (100) 100
care and treatment (99) 99
rituximab (98) 98
blood platelets - drug effects (97) 97
benzoates - adverse effects (94) 94
hydrazines - adverse effects (94) 94
pyrazoles - adverse effects (94) 94
adolescent (89) 89
thrombopoietin - adverse effects (88) 88
aged, 80 and over (84) 84
benzoates - administration & dosage (84) 84
hydrazines - administration & dosage (84) 84
pyrazoles - administration & dosage (84) 84
chronic disease (83) 83
adults (81) 81
patients (81) 81
platelet production (79) 79
recombinant fusion proteins - adverse effects (79) 79
analysis (77) 77
abridged index medicus (75) 75
receptors, thrombopoietin - metabolism (74) 74
thrombopoietin receptor agonists (74) 74
young adult (74) 74
thrombopoietin - administration & dosage (73) 73
child (72) 72
idiopathic thrombocytopenic purpura (71) 71
thrombopoietin - metabolism (70) 70
c-mpl (69) 69
immune thrombocytopenic purpura (69) 69
medicine & public health (69) 69
purpura, thrombocytopenic, idiopathic - blood (69) 69
c-mpl ligand (68) 68
receptors, fc - administration & dosage (68) 68
hemic and lymphatic diseases (67) 67
children (66) 66
cell biology (64) 64
in-vitro (64) 64
medicine, general & internal (64) 64
recombinant fusion proteins - administration & dosage (64) 64
bone marrow (63) 63
thrombopoietin-receptor agonists (63) 63
stem cells (62) 62
blood platelets - metabolism (59) 59
drug therapy (59) 59
health aspects (58) 58
research (57) 57
recombinant human thrombopoietin (56) 56
therapy (56) 56
thrombocytopenic purpura (56) 56
thrombosis (55) 55
human megakaryocyte growth (54) 54
thrombopoiesis - drug effects (54) 54
adult patients (51) 51
long-term (51) 51
cancer (50) 50
dose-response relationship, drug (50) 50
pharmacokinetics (50) 50
purpura, thrombocytopenic, idiopathic - therapy (50) 50
hydrazines - pharmacology (49) 49
pyrazoles - pharmacology (49) 49
retrospective studies (49) 49
signal transduction (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1011) 1011
Japanese (22) 22
French (17) 17
Spanish (7) 7
Polish (4) 4
Russian (4) 4
German (3) 3
Chinese (1) 1
Danish (1) 1
Dutch (1) 1
Norwegian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


HAMOSTASEOLOGIE, ISSN 0720-9355, 08/2019, Volume 39, Issue 3, pp. 272 - 278
Management of patients with corticosteroid-refractory immune thrombocytopaenia (ITP) possesses a significant challenge to practitioners. Until recently,... 
ADULT PATIENTS | EFFICACY | immune thrombocytopenia | BONE-MARROW RETICULIN | OPEN-LABEL | second-line therapy | thrombopoietin-receptor agonists | DOUBLE-BLIND | ELTROMBOPAG | QUALITY-OF-LIFE | JAPANESE PATIENTS | HEMATOLOGY | LONG-TERM TREATMENT | RECEIVING ROMIPLOSTIM
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 09/2018, Volume 16, Issue 9, pp. 1700 - 1710
Journal Article
STEM CELLS, ISSN 1066-5099, 02/2009, Volume 27, Issue 2, pp. 424 - 430
Journal Article
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 05/2019, Volume 136, pp. 60 - 75
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 09/2019, Volume 41, Issue 9, pp. 1747 - 1754.e2
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2018, Volume 183, Issue 3, pp. 479 - 490
Summary Avatrombopag, an oral thrombopoietin receptor agonist, was compared with placebo in a 6‐month, multicentre, randomised, double‐blind, parallel‐group... 
platelet count | thrombopoietin | bleeding disorders | thrombocytopenia | platelet disorders | MANAGEMENT | EFFICACY | ITP | SAFETY | PURPURA | ROMIPLOSTIM | ADULTS | CHILDREN | ELTROMBOPAG | HEMATOLOGY | LONG-TERM TREATMENT | Thrombocytopenia | Care and treatment | Headache | Randomization | Response rates | Adults | Safety | Platelets | Patients | Bleeding | Thrombopoietin | Platelets, Haemostasis and Thrombosis | Research Paper
Journal Article